Immanuel Lerner, Ph.D.

Founder, Director and CEO @ Pepticom Ltd.

About

I am a scientist and biotech entrepreneur with a proven track record in envisioning and establishing a successful AI/biotech startup. I co-invented, founded and currently I am leading Pepticom, a disruptive company in the field of AI-based peptide drug discovery/design. I led Pepticom from concept to revenue generation via collaboration with large multinational companies, negotiated and executed discovery deals and seed/Round A finance. My 15-year academic career prior to the establishment of Pepticom includes a Ph.D. in biochemistry followed by postdoctoral research at the Hebrew University of Jerusalem. During my studies, I published research in leading journals such as Blood, Nature Communications, the Journal of Clinical Investigation, Cancer Research, and others, and had the honor of publishing my postdoc research with the 2017 Nobel Laureate in Physiology/Medicine Prof. Michael Rosbash.

Country

City

Israel

Industry

Pharmaceuticals

Skill

Cell Biology, Immunofluorescence, Biochemistry, Tissue Culture, Molecular Biology, Animal Models, Confocal Microscopy, Cell Culture, Cancer Research, Cell, Genetics, Transfection, Molecular Cloning, Immunoprecipitation, Fluorescence Microscopy, Microscopy, Protein Expression, In Vivo, Western Blotting, Immunohistochemistry

Experience

Founder, Director and CEO

Pepticom Ltd.

2013-10 - Present · 13 yrs

Jerusalem

Pepticom developed and is constantly improving its AI platform for peptide discover, the platform enables the discovery of peptides with non-natural modifications (>180 building blocks) with different cyclization chemistries. Pepticom’s technology dramatically cuts time/cost/risk of discovery efforts, and is used both in in-house projects and collaborations with Pharma and Agricultural companies.